SE441359B - Forfarande for framstellning av nya klavulansyratioetrar - Google Patents

Forfarande for framstellning av nya klavulansyratioetrar

Info

Publication number
SE441359B
SE441359B SE7700946A SE7700946A SE441359B SE 441359 B SE441359 B SE 441359B SE 7700946 A SE7700946 A SE 7700946A SE 7700946 A SE7700946 A SE 7700946A SE 441359 B SE441359 B SE 441359B
Authority
SE
Sweden
Prior art keywords
acidators
clavulanic
procedure
preparation
new
Prior art date
Application number
SE7700946A
Other languages
English (en)
Swedish (sv)
Other versions
SE7700946L (sv
Inventor
R J Ponsford
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3892/76A external-priority patent/GB1574906A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7700946L publication Critical patent/SE7700946L/xx
Publication of SE441359B publication Critical patent/SE441359B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
SE7700946A 1976-01-31 1977-01-28 Forfarande for framstellning av nya klavulansyratioetrar SE441359B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3892/76A GB1574906A (en) 1976-01-31 1976-01-31 Therapeutic compounds containing - lactams
GB1900276 1976-05-08

Publications (2)

Publication Number Publication Date
SE7700946L SE7700946L (sv) 1977-08-01
SE441359B true SE441359B (sv) 1985-09-30

Family

ID=26238678

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7700946A SE441359B (sv) 1976-01-31 1977-01-28 Forfarande for framstellning av nya klavulansyratioetrar

Country Status (31)

Country Link
US (2) US4428958A (xx)
JP (1) JPS5295689A (xx)
AR (3) AR214306A1 (xx)
AT (1) AT351675B (xx)
AU (1) AU515736B2 (xx)
BG (1) BG27751A3 (xx)
CA (1) CA1089471A (xx)
CH (2) CH637655A5 (xx)
CS (1) CS196341B2 (xx)
DD (1) DD128196A5 (xx)
DE (1) DE2702954A1 (xx)
DK (1) DK146940C (xx)
ES (1) ES455404A1 (xx)
FI (1) FI63581C (xx)
FR (1) FR2339616A1 (xx)
GR (1) GR62544B (xx)
HK (1) HK69883A (xx)
IE (1) IE44759B1 (xx)
IL (1) IL51267A (xx)
KE (1) KE3303A (xx)
LU (1) LU76668A1 (xx)
MX (1) MX4950E (xx)
NL (1) NL7700892A (xx)
NO (1) NO770279L (xx)
NZ (1) NZ183117A (xx)
PH (1) PH13924A (xx)
PT (1) PT66071B (xx)
RO (1) RO69712A (xx)
SE (1) SE441359B (xx)
SU (1) SU645583A3 (xx)
YU (1) YU10777A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
GB2004541B (en) * 1977-09-16 1982-05-12 Beecham Group Ltd Ethers of clavulanic acid a process for their preparation and pharmaceutical compositions containing them
EP0008899B1 (en) * 1978-09-05 1982-09-15 Beecham Group Plc Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
EP0018203B1 (en) * 1979-04-21 1983-03-02 Beecham Group Plc Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
NZ193687A (en) * 1979-05-17 1982-12-21 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039673A (en) 1973-10-30 1977-08-02 Bayer Aktiengesellschaft Penicillins and cephalosporins and their production
US3983113A (en) 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials

Also Published As

Publication number Publication date
LU76668A1 (xx) 1977-06-28
US4428958A (en) 1984-01-31
MX4950E (es) 1983-01-12
GR62544B (en) 1979-05-07
IL51267A (en) 1979-12-30
YU10777A (en) 1982-06-30
PT66071A (en) 1977-02-01
AR216555A1 (es) 1979-12-28
NL7700892A (nl) 1977-08-02
NZ183117A (en) 1979-10-25
CH637655A5 (de) 1983-08-15
BG27751A3 (en) 1979-12-12
DD128196A5 (de) 1977-11-02
RO69712A (fr) 1980-07-15
KE3303A (en) 1983-08-05
ATA53477A (de) 1979-01-15
PH13924A (en) 1980-11-04
FR2339616A1 (fr) 1977-08-26
ES455404A1 (es) 1978-05-01
IE44759L (en) 1977-07-31
DK146940B (da) 1984-02-20
FI770295A (xx) 1977-08-01
FR2339616B1 (xx) 1980-04-11
CA1089471A (en) 1980-11-11
DK146940C (da) 1984-07-30
CS196341B2 (en) 1980-03-31
DK38577A (da) 1977-08-01
US4505894A (en) 1985-03-19
AR216925A1 (es) 1980-02-15
PT66071B (en) 1978-06-23
HK69883A (en) 1983-12-23
SE7700946L (sv) 1977-08-01
NO770279L (no) 1977-08-02
CH638529A5 (de) 1983-09-30
AU515736B2 (en) 1981-04-30
JPS5295689A (en) 1977-08-11
FI63581C (fi) 1983-07-11
SU645583A3 (ru) 1979-01-30
AR214306A1 (es) 1979-05-31
DE2702954A1 (de) 1977-08-04
IL51267A0 (en) 1977-03-31
AT351675B (de) 1979-08-10
IE44759B1 (en) 1982-03-24
JPS613349B2 (xx) 1986-01-31
AU2177077A (en) 1978-08-03
FI63581B (fi) 1983-03-31

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE464580B (sv) Foerfarande foer framstaellning av nya cefalosporinderivat
SE464581B (sv) Foerfarande foer famstaellning av nya cefalosporinderivat
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE7703715L (sv) Framstellning av nya aminokromanoler
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE441359B (sv) Forfarande for framstellning av nya klavulansyratioetrar
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE425493B (sv) Forfarande for framstellning av nya estrar av testosteron
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE435716B (sv) Forfarande for framstellning av nya penicilliner
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE416545B (sv) Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7700946-2

Effective date: 19870915

Format of ref document f/p: F